Friday, August 21

Browsing: bioorthogonallike

Research

Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING

By NewsCancerAugust 19, 20260

Pardi, N. & Krammer, F. mRNA vaccines for infectious diseases—advances, challenges and opportunities. Nat. Rev. Drug Discov. 23, 838–861 (2024).Article …

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.

What's Hot

Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis

Lenvatinib/Pembrolizumab Shows Promise After IO Progression in GYN Cancers

FDA Issues Another CRL for Amorphous Dasatinib Receives in CML and ALL

Browsing: bioorthogonallike

Enhanced antitumor immunity of mRNA vaccines by bioorthogonal-like delayed activation of exogeneous STING

Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis

Lenvatinib/Pembrolizumab Shows Promise After IO Progression in GYN Cancers

FDA Issues Another CRL for Amorphous Dasatinib Receives in CML and ALL

Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say

Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis

Lenvatinib/Pembrolizumab Shows Promise After IO Progression in GYN Cancers

FDA Issues Another CRL for Amorphous Dasatinib Receives in CML and ALL

Personalized Vaccine Helped Melanoma Patients Stay Cancer-Free Longer, Drugmakers Say

Latest Post

Clinical-stage human anti-transferrin receptor antibodies suppress colorectal cancer metastasis

Lenvatinib/Pembrolizumab Shows Promise After IO Progression in GYN Cancers

FDA Issues Another CRL for Amorphous Dasatinib Receives in CML and ALL

Subscribe to Updates

What's Hot

Browsing: bioorthogonallike